Per Protocol Population Sample Clauses
The 'Per Protocol Population' clause defines the subset of study participants who have adhered strictly to the clinical trial protocol and are therefore included in specific analyses. This group typically excludes individuals who deviated from key study procedures, missed critical visits, or failed to take the investigational product as directed. By focusing on participants who followed the protocol as intended, this clause ensures that the study's efficacy results reflect the treatment's effect under ideal conditions, thereby providing a clearer assessment of the intervention's true efficacy.
POPULAR SAMPLE Copied 2 times
Per Protocol Population. The Per Protocol Population includes all patients who meet the study entry criteria and provide complete data, are at least 90% compliant with study treatment, and have no dose adjustments.
Per Protocol Population. The Per-Protocol (PP) population includes subjects in the mITT population who complied with treatment and did not have any protocol violations. A protocol violation is defined as a deviation from basic requirements of the study protocol, including inclusion and exclusion criteria, concomitant medication restrictions, or any other protocol requirements that result in a significant added risk to the study subject or has an impact on the quality of the data collected or the outcome of the study. A protocol deviation is defined as a deviation from the protocol that does not impose added risk to the study design or the study subject. The criteria for the determination of the evaluability of subjects will be defined in the Statistical Analysis Plan.
Per Protocol Population. Subjects in the ITT population who have no protocol violations, received no bisphosphonates or inhaled chronic antibiotics from 7 days prior to Day 1 through